1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 33447351 | Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation. | 2020 Dec 29 | 2 |